BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder
BrainsWay presented positive real-world data from a 462-patient study showing an 83.5% response rate in PTSD symptoms for comorbid patients treated with Deep TMS. The data also indicated strong efficacy for depression, with a 66.6% response rate and a 27.3% remission rate among the study participants.
Key figures
- Patient count
- 462
- Mdd response rate
- 66.6%
- Mdd remission rate
- 27.3%
- Mean mdd reduction
- 50%
- Ptsd response rate
- 83.5%
- Mean ptsd reduction
- 52%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.